Athletes take L-carnitine supplements to improve their athletic performance, recover from workouts and fight off fatigue
The authors conclude: In this real-world study where half of patients discontinued GLP-1-based treatment within a year after initiation, not losing weight was associated with worse clinical outcomes while larger reductions were associated with decreased risks
As awareness grows and access improves, the impact will become much more widespread. Barrett noted that GLP-1 users are already purchasing fewer ready-made meals and sweets, instead opting for protein-rich foods, lighter meals and increased water consumption
The drug received approval from both the US FDA and the European Union in 2022 for the treatment of type 2 diabetes, demonstrating signicant glucose-lowering and weight-loss efects in multiple clinical trials
However, future studies using more detailed clinical data need to be conducted to fully grasp the prescribing patterns and potential misuse of the subsidies